Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,173,592
-$3,390,669 QoQ
Shares Held
159,677
-5.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#321
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRUDENTIAL PLC holds $379,910,977 across 10 Drug Manufacturers - General names. GILD ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
400,991 | $101,839,684 | |
| 2 | LLY |
ELI LILLY & Co
|
75,814 | $90,933,592 | |
| 3 | MRK |
Merck & Co., Inc.
|
344,478 | $44,265,422 | |
| 4 | ABBV |
AbbVie Inc.
|
158,913 | $39,988,867 | |
| 5 | AZN |
Astrazeneca PLC
|
170,573 | $32,344,052 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
159,677 | $20,173,592 | |
| 7 | AMGN |
Amgen Inc
|
49,223 | $17,824,631 | |
| 8 | PFE |
Pfizer Inc
|
719,586 | $17,327,630 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,173,592 | 159,677 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $23,564,261 | 169,077 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $21,280,170 | 173,376 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $20,292,798 | 182,818 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $21,563,660 | 194,495 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $24,909,163 | 222,304 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $23,800,331 | 257,663 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $23,559,375 | 281,004 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $21,897,704 | 319,162 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $25,738,585 | 351,380 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $16,176,319 | 199,683 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $16,451,353 | 219,527 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $15,789,330 | 204,870 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,641,413 | 212,624 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $19,402,872 | 226,009 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $11,285,630 | 182,941 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,329,587 | 183,297 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,730,792 | 197,322 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,043,070 | 55,682 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,826,437 | 26,148 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $9,124,018 | 132,501 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $17,106,785 | 264,688 | Shares | Defined | 2021-05-14 | |
| 2020-06-30 | $143,346,990 | 1,863,101 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $107,081,812 | 1,432,341 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||